Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GC007g
- Development stage
- Phase 1
- Lead developer
- Gracell Biotechnologies
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
GC007g is a **donor-derived, allogeneic chimeric antigen receptor T cell (CAR-T) therapy** targeting CD19, developed for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) in patients who have relapsed after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and are not eligible for autologous CAR-T therapy due to poor cell quality or infections[1][2][3][4][7][9]. GC007g CAR-T cells are manufactured from T cells donated by HLA-matched healthy donors, genetically engineered to express a CAR directed against CD19[2][4]. The therapy has demonstrated high overall response rates and a favorable safety profile in phase 1 trials, with notable efficacy for inducing durable remission in the post-transplant r/r B-ALL patient population[1][3][7].
- Brand names
- GC007gGC-007gGC 007g
- Other names
- GC007gGC-007gGC 007g
02
Targets
Beyond the preview
Go deeper on GC007g.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GC007g.